title: Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
authors.forename: Phyllis A
authors.initials: PA
authors.lastname: Gimotty
authors.forename: DuPont
authors.initials: D
authors.lastname: Guerry
authors.forename: Keith
authors.initials: K
authors.lastname: Flaherty
mesh_terms: D019985:Benchmarking; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008545:Melanoma / Q000401:mortality* / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D012107:Research Design / Q000592:standards; D018401:Sample Size; D012878:Skin Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*